Global

Search

Filter by category
reset filters
AeroEclipse BAN viewed from the left

AEROECLIPSE* II BAN* Nebulizer

7 days, reusable – ideal for the hospital environment.

View details
Elderly woman coughing

Dry Powder Inhalers (DPIs) vs Metered Dose Inhaler (MDI) with Valved Spacer : Using Functional Respiratory Imaging (FRI) to Assess Modelled Lung Deposition in a COPD patient

  • The FRI deposition profiles highlight that the MDI/AeroChamber Plus* Flow-Vu* VHC delivered a significantly greater percentage of drug to the lung region than either of the two DPIs, irrespective of flow rate.
  • This was reflected in much higher modelled oropharyngeal deposition for the two DPIs.
  • The influence of inhalation flow profile was significant for one of the DPIs.
View details
Using Functional Respiratory Imaging

Using Functional Respiratory Imaging (FRI) to Compare Predicted Airway Deposition Between Pressurized Metered Dose Inhaler (pMDI) with AeroChamber Plus* Flow-Vu* Valved Holding Chamber (VHC) and Two Dry Powder Inhalers (DPIs) in a COPD patient

This study was presented at the Drug Delivery to the Lungs Conference, 2022.

View details

AEROLIV* App: Asthma + COPD Mentor

Stress less symptom control 
View details

News and Publications

Recent News and Publications for Patients, Consumers and Health Professionals
View details
australian flag

Trudell Medical International Announces Expansion to Australia!

Today Trudell Medical International announces it is extending its global footprint with its expansion into the Australian market with the establishment of Trudell Medical Australia Propriety Limited (Trudell Medical Australia).

View details
good design ac2go banner

AeroChamber2go* Spacer Receives Prestigious GOOD DESIGN® Award

The AeroChamber2go* Spacer has been honored with a GOOD DESIGN® Award, the world’s oldest and most prestigious design program. The unique 2-in-1 spacer and protective inhaler case has been recognized for its innovative design, which benefits patients, the healthcare system, and the environment.  

View details

Living with COPD

Chronic Obstructive Pulmonary Disease (COPD) affects around 251 million people globally.1 It is a term that covers two types of chronic (long-term) diseases where the airways in the lungs become “obstructed” or partly blocked.

View details